In studies of lung cancer, renal clear cell carcinoma, hepatocellular carcinoma and esophageal cancer, patients with high expression of USP53 also showed better survival outcomes, suggesting that USP53 may be a broad-spectrum prognostic protective factor for cancer [14–17]. This evidence concerns the gene USP53 and lung carcinoma.